Prévisions
L'objectif de cours moyen des analystes est de 9,11 € (+423,56 %). La médiane est de 9,11 € (+423,56 %).
| Acheter |
4 |
| Conserver |
14 |
| Vendre |
2 |
Discussions dans la communauté
Il n'y a pas encore de discussion sur cet actif.
Lancer une discussionActualités Accéder au fil d'actualités
Tilray Brands converts $12 million of debt into 2,841,650 common shares
Tilray Brands carried out private transactions between August 31 and September 8 and issued 2,841,650 unregistered common shares in exchange for $12 million principal amount of its 5.20% convertible senior notes due June 15, 2027. The transactions were with independent third parties and relied on the Section 3(a)(9) exemption of the Securities Act of 1933. » Plus sur de.investing.com
Tilray Brands to buy HelloMD and build vertically integrated medical cannabis platform in Canada
Tilray Brands announced on June 29 that it will acquire HelloMD's Canadian medical cannabis assets after winning a court-approved sale process. The deal pairs HelloMD's digital telehealth and patient engagement platform with Tilray's cultivation, clinical expertise and national fulfillment to create a connected pathway for patients and practitioners. Tilray highlighted opportunities to expand into adjacent wellness categories like sleep and pain support; financial terms were not disclosed. Shares of Tilray are down more than 50% year-to-date. » Plus sur finance.yahoo.com
Données financières
Au dernier trimestre, TILRAY BRANDS NEW O.N. a réalisé un chiffre d'affaires de 221,35 M € et un bénéfice net de -37,13 M €
| (EUR) | août 2026 | YoY |
|---|---|---|
| Chiffre d'affaires | 221,35 M | 23,51 % |
| Bénéfice brut | 66,72 M | 35,72 % |
| Bénéfice net | -37,13 M | 13 382,06 % |
| EBITDA | -11,35 M | 161,77 % |
Données fondamentales
| Indicateur | Valeur |
|---|---|
Capitalisation boursière | 229,32 M € |
Nombre d'actions | 111,83 M |
Plus haut/bas sur 52 semaines | 14,31 € - 2,03 € |
| Dividendes | Non |
Bêta | 2,05 |
Ratio P/E | -1,61 |
Ratio PEG | -0,02 |
Ratio P/B | 0,18 |
Ratio P/S | 0,26 |
Profil de l'entreprise
| Nom | TILRAY BRANDS NEW O.N. |
| PDG | Irwin David Simon |
| Siège social | Leamington,
on États-Unis |
| Site web | |
| Secteur | Santé |
| Industrie | Biotechnologie |
| Employés | 3 595 |